Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

HSR&D Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Questions and controversy surrounding the FDA warning for citalopram.

Zivin K. Questions and controversy surrounding the FDA warning for citalopram. Paper presented at: Dartmouth Center for Aging Research Group Meeting; 2014 May 12; Waterville Valley, NH.

No abstract provided for this citation.




Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.